Personalized treatment planning for older adults with lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study helps doctors create a personalized treatment plan for older adults with lung cancer based on a comprehensive review of their health. It aims to choose the best treatment to improve quality of life and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 90 years old.
- You have been diagnosed with non-small cell or small cell lung cancer.
- Your cancer is at any stage (I to IV).
- You are able to take care of yourself and are not bedridden.
- You are expected to live at least 3 more months.
- You can undergo standard tests like CT scans, MRIs, and lung function tests, and are able to receive at least one type of cancer treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a personalized treatment for non-small cell lung cancer that uses a patient's own immune cells to fight the tumor. It may help patients with early or advanced stages of the disease.
This trial uses real-world data to study how to personalize treatment for advanced non-small cell lung cancer. It looks at medical records from 2011 to 2024 to find the best therapy approaches.
This trial uses your tumor sample to guide personalized treatment decisions for certain lung cancers. It may help by matching you to a more targeted plan based on genetic testing and your prior treatment history.
This study compares getting both chemotherapy and immunotherapy versus immunotherapy alone for older adults with advanced lung cancer. The goal is to see which approach is more effective and tolerable for people aged 70 and older.
This trial tests a quality-of-life support program meant to help people with early-stage lung cancer think through their treatment choices. It may help you feel more informed and more confident about deciding between treatments like surgery and SBRT.
This trial tests a new way to choose the best treatment for your lung cancer by creating a model of your tumor in the lab. It may help doctors find the most effective therapy for you.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.